Table 1 Baseline characteristics of the study population in the association analysis.
From: A multi-omics study of circulating phospholipid markers of blood pressure
Discovery | Replication | ||||
|---|---|---|---|---|---|
CROATIA-Vis | ERF | NSPHS | ORCADES | MICROS | |
N | 710 | 717 | 678 | 681 | 1,185 |
Age (y) | 56.6 (15.6) | 51.9 (14.2) | 47.1 (20.8) | 57.0 (13.9) | 45.7 (16.4) |
Sex (% women) | 57.40 | 59.00 | 53.2 | 57.9 | 56.0 |
Body mass index (kg/m2) | 27.4 (4.3) | 27.0 (4.4) | 26.4 (4.8) | 27.7 (4.8) | 25.6 (4.8) |
HDL-C (mmol/L) | 1.10 (0.16) | 1.29 (0.36) | 1.60 (0.41) | 1.57 (0.42) | 1.68 (0.38) |
TC (mmol/L) | 5.12 (0.99) | 5.67 (1.08) | 5.86 (1.33) | 5.56 (1.14) | 5.87 (1.19) |
Lipid-lowering medication use (%) | 3.00 | 16.60 | 10.47 | 4.10 | 5.47 |
Systolic blood pressure (mmHg) | 137.8 (24.45) | 141.7 (22.0) | 122.8 (18.6) | 130.1 (18.46) | 132.6 (20.5) |
Diastolic blood pressure (mmHg) | 80.5 (11.47) | 80.6 (10.24) | 74.1 (7.8) | 76.0 (9.6) | 79.6 (11.3) |
Antihypertensive medication use (%) | 24.1 | 25.2 | 20.5 | 39.1 | 14.6 |
Type 2 diabetes (%) | 4.2 | 6.0 | 4.1 | 2.8 | 3.1 |
